Clinical Trial Update: A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease [Phase 1]

View source ↗

Summary

Phase 1 trial of TQC3927 powder for inhalation in chronic obstructive pulmonary disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TQC3927

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED